Value
8.9/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 9.0 |
| P/S | 9.9 |
| EV/EBITDA | 9.0 |
| Fwd P/E | 9.9 |
| PEG | 10.0 |
| Analyst target | 6.0 |
- ▸Forward P/E: 5.5x
- ▸PEG: 0.48
- ▸Attractively valued
EEFT · Why this verdict
Why Euronet Worldwide (EEFT) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.3/10
ConfidenceHIGH
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
At a forward P/E of 5.5x and a PEG of 0.47, the stock is priced for distress the fundamentals do not obviously justify, with institutional accumulation diverging from the price trend. However, a confirmed downtrend, 12% short interest, and heavy revenue concentration in a single segment create real near-term headwinds that must be weighed carefully.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
A single product segment accounts for 73% of total revenue, creating concentrated exposure to that segment's performance; combined with a debt-to-equity ratio of 2.2 and uneven earnings execution, the downside scenario carries more weight than the headline valuation discount suggests. Bear case | Revenue concentration in the dominant segment falls below 55% of total revenue for 2 consecutive fiscal periods, demonstrating meaningful diversification. | →Stable |
| CounterHigh concentration in a single growth segment can amplify upside as well — if that segment accelerates, earnings leverage to it would compound the bull case with no diversification drag. | ||
At a forward P/E of 5.5x and a PEG of 0.47, the stock screens as attractively valued among peers, and analyst consensus implies roughly 15% upside to the consensus target from the current price — with a risk/reward ratio of approximately 2.1-to-1 in the investor's favor. Valuation breakdown | Share price closes above $76.85 (the analyst consensus target) within 12 months as the valuation discount narrows. | →Stable |
| CounterA cheap multiple can persist or compress further when price momentum is deteriorating; a confirmed downtrend with the 200-day moving average sloping steeply negative creates a meaningful headwind to any near-term re-rating. | ||
Institutional investors have been accumulating shares despite the falling price, a divergence between informed positioning and the near-term price trend that can precede stabilization or recovery. Insider breakdown | Institutional ownership increases for 2 consecutive reported quarters while short interest falls below 8% of float. | →Stable |
| CounterInstitutional accumulation data carries a lag and may reflect passive index demand or value mandates rather than active conviction; the 12% short interest shows a significant portion of sophisticated capital is positioned in the opposite direction. | ||
The stock's 200-day moving average is sloping at -5.4% per month in a confirmed downtrend, with a death cross formation blocking momentum-sensitive buyers and keeping the near-term risk skewed toward further weakness. Momentum breakdown | The 200-day moving average slope turns positive (above 0% per 30 days) and the death cross resolves into a golden cross within 9 months. | →Stable |
| CounterVolume accumulation via a rising OBV is occurring concurrently with the price decline, indicating buyers are stepping in at lower prices — a divergence that could accelerate a trend reversal sooner than the moving average slope alone would suggest. | ||
A single product segment accounts for 73% of total revenue, creating concentrated exposure to that segment's performance; combined with a debt-to-equity ratio of 2.2 and uneven earnings execution, the downside scenario carries more weight than the headline valuation discount suggests.
→StableBear case
- Expectation
- Revenue concentration in the dominant segment falls below 55% of total revenue for 2 consecutive fiscal periods, demonstrating meaningful diversification.
CounterHigh concentration in a single growth segment can amplify upside as well — if that segment accelerates, earnings leverage to it would compound the bull case with no diversification drag.
At a forward P/E of 5.5x and a PEG of 0.47, the stock screens as attractively valued among peers, and analyst consensus implies roughly 15% upside to the consensus target from the current price — with a risk/reward ratio of approximately 2.1-to-1 in the investor's favor.
→StableValuation breakdown
- Expectation
- Share price closes above $76.85 (the analyst consensus target) within 12 months as the valuation discount narrows.
CounterA cheap multiple can persist or compress further when price momentum is deteriorating; a confirmed downtrend with the 200-day moving average sloping steeply negative creates a meaningful headwind to any near-term re-rating.
Institutional investors have been accumulating shares despite the falling price, a divergence between informed positioning and the near-term price trend that can precede stabilization or recovery.
→StableInsider breakdown
- Expectation
- Institutional ownership increases for 2 consecutive reported quarters while short interest falls below 8% of float.
CounterInstitutional accumulation data carries a lag and may reflect passive index demand or value mandates rather than active conviction; the 12% short interest shows a significant portion of sophisticated capital is positioned in the opposite direction.
The stock's 200-day moving average is sloping at -5.4% per month in a confirmed downtrend, with a death cross formation blocking momentum-sensitive buyers and keeping the near-term risk skewed toward further weakness.
→StableMomentum breakdown
- Expectation
- The 200-day moving average slope turns positive (above 0% per 30 days) and the death cross resolves into a golden cross within 9 months.
CounterVolume accumulation via a rising OBV is occurring concurrently with the price decline, indicating buyers are stepping in at lower prices — a divergence that could accelerate a trend reversal sooner than the moving average slope alone would suggest.
Per-dimension breakdown
Quality
4.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 8.2 |
| ROA | 3.5 |
| Gross margin | 0.9 |
| Op margin | 2.8 |
| Net margin | 3.6 |
| Current ratio | 4.8 |
| FCF quality | 7.6 |
| Moat | 6.0 |
| Piotroski F | 4.4 |
Growth
3.3/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 5.1 |
| EPS growth | 1.5 |
Momentum
5.4/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 8.4 |
| OBV | 10.0 |
| MA position | 4.0 |
| Volume | 0.0 |
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope -5.1%/30d — confirmed downtrend
Sentiment
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.6 |
| Price target | 8.6 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (6.0) — signal dampened
- ▸Analyst upside: 30%
Insider
5.3/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.5 |
| holder change | 5.1 |
- ▸Insider buying (low materiality) — $175,760 (0.007% of mkt cap)
Peer rank
4.5/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 9.1 |
| quality rank | 5.7 |
| growth rank | 3.3 |
- ▸Attractive P/E vs peers
Technical
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.9 |
| support resistance | 5.4 |
| 52w position | 1.9 |
Risk (lower is worse)
4.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 3.8 |
| days to cover | 4.2 |
| volatility | 3.0 |
| put call | 0.0 |
| implied vol | 5.3 |
| max pain risk | 7.0 |
| beta | 8.0 |
| debt equity | 2.8 |
- ▸Elevated put/call: 2.58
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
4.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 2.8 |
- ▸Earnings concerns: 2B/2M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:5.4>=4.5
- ASYMMETRY:1.7>=1.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:34d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (3)
- MOMENTUM:5.4<5.5 (soft — BUY_NOW allowed but watch)
- DEATH_CROSS:momentum=5.4>=5.0 recovering
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
1.67
Upside
+13.2%
Downside
7.9%
Sizing output
AVOID
SetupRECOVERY — Death cross but MACD improving, RSI 42
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $2.6B<$5B
Investment implication
The F-path SELL output reflects an overall score of 3.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 8.9) was not enough to lift the adjusted overall above the threshold. Current asymmetry R:R is 1.67 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 8.9, Sentiment at 6.8, and Momentum at 5.4; the weakest are Growth at 3.3, Catalyst at 4.0, and Technical at 4.1. The V9 engine cleared all gates with 3 warnings, producing an asymmetric reward-to-risk of 1.67 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1At a forward P/E of 5.5x and a PEG of 0.47, the stock screens as attractively valued among peers, and analyst consensus implies roughly 15% upside to the consensus target from the current price — with a risk/reward ratio of approximately 2.1-to-1 in the investor's favor.
Trip ifAnalyst consensus target is cut below $70 (less than 5% above the current price of $66.90), eliminating the upside thesis.
- P2Institutional investors have been accumulating shares despite the falling price, a divergence between informed positioning and the near-term price trend that can precede stabilization or recovery.
Trip ifInstitutional ownership falls for 2 consecutive reported quarters while short interest remains above 10%.
- P3The stock's 200-day moving average is sloping at -5.4% per month in a confirmed downtrend, with a death cross formation blocking momentum-sensitive buyers and keeping the near-term risk skewed toward further weakness.
Trip ifThe 200-day moving average slope turns positive (above 0% per 30 days) and price closes above the 200-day MA for 10 consecutive trading days, resolving the downtrend concern.
- P4A single product segment accounts for 73% of total revenue, creating concentrated exposure to that segment's performance; combined with a debt-to-equity ratio of 2.2 and uneven earnings execution, the downside scenario carries more weight than the headline valuation discount suggests.
Trip ifRevenue concentration in the dominant product segment falls below 55% of total revenue for 2 consecutive fiscal periods, demonstrating meaningful diversification.